For over a quarter-century, this actively managed portfolio has offered investors an economical gateway to companies worldwide operating within the healthcare sector. Its holdings encompass pharmaceutical giants, medical equipment manufacturers, and cutting-edge research organizations. Compared to its peers in the healthcare space, this fund typically exhibits broader international exposure and a lower portfolio turnover rate.
